Slavitt: Mylan Owes Medicaid Rebates For Misclassifying EpiPen

In his final days as CMS acting administrator, Andy Slavitt told Senate Judiciary Chair Charles Grassley (R-IA) in a letter Wednesday (Jan. 18) that Mylan owes rebates to the Medicaid because EpiPen was misclassified as a generic, as well as an additional rebate applied to companies that raise the prices of drugs faster than the rate of inflation. Senate Finance Committee Chair Orrin Hatch (R-UT) and Republican leaders of the House Energy & Commerce Committee asked Slavitt whether EpiPen qualified...